This Week in Startups

Genomes Unlocked: Anne Wojcicki's Vision for 23andMe and the Future of Proactive Healthcare | E1858

30 snips
Dec 5, 2023
Anne Wojcicki, the founder and CEO of 23andMe, talks about the groundbreaking reduction in genome sequencing costs, which now stand at just $99. She emphasizes how genetic testing can empower individuals to take proactive control of their health and discusses the curious role of genetic variations in disease resistance. The conversation also explores the integration of AI in healthcare and the importance of preventative approaches in modern health management, positioning genetic insights as crucial for future healthcare innovations.
Ask episode
AI Snips
Chapters
Transcript
Episode notes
INSIGHT

Proactive Healthcare

  • Consumers are proactively seeking healthcare solutions outside traditional systems.
  • This trend is evident in the success of self-pay health and wellness apps like Calm.
ADVICE

Genetic Information and Healthcare

  • Get genetic information proactively, even if it requires self-pay.
  • Use this information to guide healthcare providers and advocate for personalized care.
ANECDOTE

Late Diagnosis

  • Anne Wojcicki's father's exome sequencing revealed a key heart condition mutation shortly before his death.
  • This emphasizes the importance of genetic testing, even with good medical care.
Get the Snipd Podcast app to discover more snips from this episode
Get the app